Tuesday, July 03, 2018
Breaking Down What USF's Preeminence Means

In the minutes following last week's Florida Board of Governors' vote establishing the University of South Florida (USF) as the state's third preeminent university, USF System President Judy Genshaft was savoring the accomplishment, but already looking ahead. ..

Read More
Tuesday, September 15, 2015
Perspective: Records requests hijack scientists' time

"There are so many things I'd prefer to spend money on than taxpayer-funded witch hunts. Like the search to alleviate human suffering rooted in starvation and malnutrition, for example." ..

Read More
Friday, November 22, 2013
UT president Bill Powers lobbying Congress to restore research funds

Bill Powers, president of the University of Texas at Austin, will be making the rounds today at the Capitol, urging lawmakers to restore funding for university research. ..

Read More
Tuesday, November 05, 2013
Opinion: Who We Work For On winning hearts, minds, and votes for science

In chartering the National Academy of Sciences 150 years ago, President Abraham Lincoln had the wisdom to establish a body that would provide scientific advice to the nation. Lincoln also had the wisdom to know that science doesn’t advance in a vacuum; he knew that there are political frames for science, which must serve—and be perceived to serve—the public’s interest.  ..

Read More
Tuesday, October 22, 2013
Congressman Young ramped up universities’ research portfolios

Congressman C.W. Bill Young, who died Friday night, did a great deal for so many. The bulk of the recent commentary about him has focused on our Tampa Bay area. That is appropriate. But what many might not know is what Young did to ramp up university research across this great state. ..

Read More
Monday, February 04, 2013
Bill Would Drastically Increase State Funding For High-Tech Startups

When Florida researchers have a great idea for a new drug or other technology, they can hire private consultants to help bring their brainchild to life in the marketplace. Or they can get business help—for free—from the state-run tech incubator. That organization is saying, it’s been so successful that the Florida Legislature should invest five times as much in it this year.  ..

Read More
Tuesday, October 09, 2012
State University System co-sponsoring nationwide research webcast by key Federal funding agencies

Faculty, research administrators and student researchers across our State University System and the nation will be able to take free advantage of an extended live webcast later this month to learn firsthand about the research priorities and budgets of key federal agencies. The presentations are geared to the needs of those involved in seeking competitive support from the agencies. ..

Read More
Monday, December 05, 2011
NanoPhotonica Receives Funding Through New Seed Capital Accelerator Program

The Institute for the Commercialization of Public Research (the Institute) announced today that it has finalized a funding agreement with NanoPhotonica, an early-stage Orlando-based company that develops nanomaterials for next generation video displays, solar cells, and a range of other photoelectric devices. The Institute works with Florida's research universities and institutions to support new company and job creation. The goal of this program is to bridge funding gaps for early-stage companies and enable them to attract additional capital from angels, venture capital firms and others. ..

Read More
Thursday, June 30, 2011
On higher education, lessons from the north

A timely reminder of the promise of public higher education has emerged in a most unlikely place: the plains of the far north.  ..

Read More
Thursday, June 09, 2011
The Role of Public-Sector Research in the Discovery of Drugs and Vaccines

Historically, there has been a clear distinction between the roles of public-sector research and corporate research in the discovery of new drugs and vaccines to solve unmet medical needs. Public-sector research institutions (PSRIs) have performed the upstream, basic research to elucidate the underlying mechanisms and pathways of disease and identify promising points of intervention, whereas corporate researchers have performed the downstream, applied research to discover drugs that can be used to treat diseases and have then carried out the development activities to bring the drugs to market. The intellectual property that protects the investment in developing these drugs is created in the applied-research phase. ..

Read More